ProfileGDS4718 / 203424_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 70% 97% 67% 66% 56% 68% 67% 61% 63% 60% 64% 65% 69% 58% 64% 62% 72% 66% 79% 63% 65% 61% 63% 74% 71% 64% 67% 62% 59% 63% 77% 70% 59% 89% 90% 60% 71% 66% 98% 65% 53% 85% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1926961
GSM549102patient 115, normal, homogenized [OPG study]6.8756670
GSM549104patient 119, normal, homogenized [OPG study]10.85597
GSM549108patient 138, normal, homogenized [OPG study]6.593367
GSM549119patient 077, normal, homogenized [OPG study]6.5305566
GSM549133patient 032, cancer, homogenized [OPG study]5.8280356
GSM549139patient 042, cancer, homogenized [OPG study]6.7137468
GSM549099patient 107, normal, homogenized [OPG study]6.579767
GSM549109patient 139, normal, homogenized [OPG study]6.213761
GSM549110patient 046, normal, homogenized [OPG study]6.3429363
GSM549114patient 063, normal, homogenized [OPG study]6.0850260
GSM549122patient 082, normal, homogenized [OPG study]6.4142764
GSM549134patient 033, cancer, homogenized [OPG study]6.4358965
GSM549136patient 036, cancer, homogenized [OPG study]6.8652469
GSM549140patient 044, cancer, homogenized [OPG study]5.9769158
GSM549111patient 047, normal, homogenized [OPG study]6.3972864
GSM549113patient 057, normal, homogenized [OPG study]6.2357362
GSM549132patient 031, cancer, homogenized [OPG study]7.0461172
GSM549137patient 038, cancer, homogenized [OPG study]6.5907666
GSM549142patient 047, cancer, homogenized [OPG study]7.5420979
GSM549100patient 110, normal, homogenized [OPG study]6.3275863
GSM549107patient 135, normal, homogenized [OPG study]6.4743365
GSM549115patient 068, normal, homogenized [OPG study]6.1755261
GSM549116patient 072, normal, homogenized [OPG study]6.3513863
GSM549120patient 078, normal, homogenized [OPG study]7.2356274
GSM549131patient 030, cancer, homogenized [OPG study]7.0244971
GSM549118patient 074, normal, homogenized [OPG study]6.4027464
GSM549129patient 027, cancer, homogenized [OPG study]6.6890767
GSM549123patient 088, normal, homogenized [OPG study]6.2879862
GSM549124patient 006, cancer, homogenized [OPG study]6.0895359
GSM549126patient 015, cancer, homogenized [OPG study]6.3519963
GSM549128patient 025, cancer, homogenized [OPG study]7.6266777
GSM549103patient 117, normal, homogenized [OPG study]6.806270
GSM549117patient 073, normal, homogenized [OPG study]6.0098159
GSM549138patient 041, cancer, homogenized [OPG study]9.0007889
GSM549141patient 045, cancer, homogenized [OPG study]9.2588390
GSM549130patient 028, cancer, homogenized [OPG study]6.1439160
GSM549101patient 111, normal, homogenized [OPG study]6.9674571
GSM549105patient 128, normal, homogenized [OPG study]6.5278566
GSM549106patient 134, normal, homogenized [OPG study]11.442798
GSM549112patient 048, normal, homogenized [OPG study]6.4563665
GSM549125patient 011, cancer, homogenized [OPG study]5.715953
GSM549127patient 024, cancer, homogenized [OPG study]8.4450885
GSM549135patient 035, cancer, homogenized [OPG study]6.4901865